CIK 0002036042 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sionna Therapeutics, Inc.
Sign in to watch- Ticker
- SION
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-819-2020
- Business address
- 21 HICKORY DRIVE, SUITE 500, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,835,018
- in 1 filing
Net −$21,835,018. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-20 | Cloonan Michael President & CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −25,000 | 228,142 | ||
| 2025-08-20 | Ridloff Elena CFO & Head of Corp. Dev. | Sale 10b5-1 | −17,500 | $22.69 | $397K | 71,532 |
| 2025-08-19 | Ridloff Elena CFO & Head of Corp. Dev. | Sale 10b5-1 | −34,500 | $21.08 | $727K | 89,032 |
| 2025-06-27 | TPG GP A, LLC 10% owner | Purchase | +60,000 | $15.84 | $950K | 6,744,962 |
| 2025-06-12 | Viney Joanne L. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +19,959 | 19,959 | ||
| 2025-06-12 | Thompson Peter A. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +19,959 | 19,959 | ||
| 2025-06-12 | Stelzer Laurie Director | Grant or award · Non-Qualified Stock Option (right to buy) | +19,959 | 19,959 | ||
| 2025-06-12 | Ruddy Marcella K. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +19,959 | 19,959 | ||
| 2025-06-12 | Resnick Joshua Director | Grant or award · Non-Qualified Stock Option (right to buy) | +19,959 | 19,959 | ||
| 2025-06-12 | Fleming Harold Edward Director | Grant or award · Non-Qualified Stock Option (right to buy) | +19,959 | 19,959 | ||
| 2025-06-12 | Clancy Paul J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +19,959 | 19,959 | ||
| 2025-06-12 | Booth Bruce Director | Grant or award · Non-Qualified Stock Option (right to buy) | +19,959 | 19,959 | ||
| 2025-06-12 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +19,959 | 19,959 | ||
| 2025-02-10 | TPG GP A, LLC 10% owner | Conversion | +4,875,547 | 5,559,962 | ||
| 2025-02-10 | TPG GP A, LLC 10% owner | Purchase | +1,125,000 | $18.00 | $20.3M | 6,684,962 |
| 2025-02-10 | TPG GP A, LLC 10% owner | Conversion · Series Seed Preferred Stock | −1,276,276 | 0 | ||
| 2025-02-10 | TPG GP A, LLC 10% owner | Conversion · Series A Preferred Stock | −1,806,318 | 0 | ||
| 2025-02-10 | TPG GP A, LLC 10% owner | Conversion · Series B Preferred Stock | −2,275,528 | 0 | ||
| 2025-02-10 | TPG GP A, LLC 10% owner | Conversion · Series C Preferred Stock | −1,765,541 | 0 | ||
| 2025-02-10 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +5,021,990 | 5,900,779 |
Page 12 of 15 · 284 trades